Hazem Assi
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Chemokine receptors and signaling
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 45
- Cancer Immunotherapy and Biomarkers 12
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Maroun Bou Zerdan (16 shared papers)Sabine Allam (2 shared papers)Gracia Fahed (1 shared paper)Youssef Bouferraa (1 shared paper)Morgan Bou Zerdan (1 shared paper)Laurence Aoun (1 shared paper)Fadi Saadeh (6 shared papers)Rami Mahfouz (8 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Frontiers in Oncology (6 papers)Clinical Neurology and Neurosurgery (4 papers)Medicine (2 papers)JCO Global Oncology (2 papers)
- Partner nations
- LebanonUnited StatesFrance
In The Last Decade
Hazem Assi
94 papers receiving 2.6k citations
Hazem Assi's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 939
- Immunology 386
- Cancer Research 239
- Genetics 157
- Endocrinology, Diabetes and Metabolism 232
Countries citing papers authored by Hazem Assi
This map shows the geographic impact of Hazem Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazem Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazem Assi more than expected).
Fields of papers citing papers by Hazem Assi
This network shows the impact of papers produced by Hazem Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazem Assi. The network helps show where Hazem Assi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hazem Assi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metabolic Syndrome: Updates on Pathophysiology and Management in 2021 Hit paper breakdown → | 2022 | 914 |
| 2 | 2009 | 475 | |
| 3 | 2006 | 166 | |
| 4 | 2017 | 140 | |
| 5 | 2017 | 87 | |
| 6 | 2019 | 49 | |
| 7 | 2017 | 49 | |
| 8 | 2023 | 47 | |
| 9 | 2020 | 43 | |
| 10 | 2021 | 38 | |
| 11 | 2013 | 33 | |
| 12 | 2010 | 28 | |
| 13 | 2005 | 27 | |
| 14 | 2018 | 26 | |
| 15 | 2008 | 24 | |
| 16 | 2011 | 24 | |
| 17 | 2008 | 24 | |
| 18 | 2018 | 23 | |
| 19 | 2017 | 19 | |
| 20 | 2021 | 15 |
About Hazem Assi
Hazem Assi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 103 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Glioma Diagnosis and Treatment (11 papers), Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers), Cancer Genomics and Diagnostics (6 papers) and Breast Lesions and Carcinomas (6 papers). The work is most often cited by research in Oncology (939 citations), Immunology (386 citations), Cancer Research (239 citations), Genetics (157 citations) and Endocrinology, Diabetes and Metabolism (232 citations). Hazem Assi has collaborated with scholars based in Lebanon, United States and France. Frequent co-authors include Maroun Bou Zerdan, Sabine Allam, Gracia Fahed, Youssef Bouferraa, Morgan Bou Zerdan, Laurence Aoun, Fadi Saadeh, Rami Mahfouz, Omid Hamid and Ruggero Ridolfi. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Clinical Neurology and Neurosurgery, Medicine and JCO Global Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.